Denmark: compounding, and what it actually costs here
The title is the argument: Denmark: compounding, and what it actually costs here. Here is the rest of it.
The compounded arrangements changed while I was mid-thread and I was arguing from a superseded position.
Read the published criteria for my indication rather than asking. Twenty minutes, and it answered everything I had been guessing at.
Asked the pharmacist to check the wholesaler and had a definite answer in about four minutes.
Would rather be corrected in public than confident in private.
best — the order this archive was captured in
Subsidy criteria and authority requirements are published. For eligibility questions those documents are authoritative and this board is not.
The national shortage database is a primary source with expected resolution dates attached. It is public, searchable, and consistently more accurate than reporting about it.
The national shortage database is a primary source with expected resolution dates attached.
This is the distinction that makes the rest of the board legible.
This is the distinction that makes the rest of the board legible.
Disagreeing with this bit: that advice predates the change in compounded arrangements.
Country added to the title. Australia and New Zealand answers differ and the thread was unusable without it.
Country added to the title.
aussie_pbs_watch is right that the two countries are separate systems and the answers diverge.
What did the pharmacy quote for the private price?
Have you checked the shortage database directly?
Correction: that is the registration decision, not the subsidy listing. They are made by different bodies.
say which state only if it matters, but always say which country
Australia and New Zealand have different regulators, different funding bodies and different arrangements. An answer for one is not evidence about the other.
Careful, personal importation provisions are narrow and specific and the general version circulating here is wrong.
Registration by the therapeutic goods regulator establishes that a product may be supplied. Subsidy listing is a separate decision about public funding, with its own criteria and its own timetable.
personal importation rules exist and are narrow
Assumed the New Zealand position applied here. It does not, and someone corrected me politely with the actual source.
Compounded supply arrangements have changed materially in recent years. Advice predating that change describes a situation that no longer applies.
PBS listing and TGA registration are two different questions
PBS criteria are published and searchable
Agreed that the published criteria are the authority. They are searchable and most people never look.